GEn1E Lifesciences
YC S19San Francisco, US · Founded 2018 · 4 known investors
Gen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.
AI & Machine LearningBiotechHealthtechMedical DevicesArtificial IntelligenceHealthcareDrug discoveryin /gen1e-lifesciences/@GEn1ELifesci
Founders & leadership· Y Combinator alumni (S19)
RL
Ritu LalinFounder
FN
Francois NaderDirector
AL
Alan LevyDirector
NK
Noor KamruddinDirector
SB
Soujanya BhumkarExecutive Officer, Director
Investors · 4
Reported raises · per SEC filings
Form D private placements$5.5MraisedDec 2025 · 44 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Nykaa Stock And 2 Fast Growth Picks With High Insider Ownership - Simply Wall St Newssimplywall.st · 2026
- Riding the Fast Track to Pharma Success - Endurance28endurance28.com · 2024
- UMB, in partnership with alumni, wants to commercialize rare disease treatments - Technical.lytechnical.ly · 2022
- GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipelineprnewswire.com · 2022
- GEn1E - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022
- Stanford alumni founders tackle COVID-19 with StartX task forcebizjournals.com · 2022
- Inside the Silicon Valley 'brain trust' taking aim at COVID-19 - ABC Newsabcnews.go.com · 2022
- The genies in medicine that work to solve ARDS - Pronetworkpronetwork.mx · 2022